Through Adimune™, developing a transformative approach to autoimmunity—focused on restoring immune tolerance rather than suppressing the immune system.
Visit AdimuneMissions
NASDAQ: ADTX
Aditxt is a social innovation platform accelerating promising innovations with the potential to address some of our most pressing health challenges.
Aditxt actively evaluates strategic acquisitions that align with its immune health focus, enhance its technology pipeline, and/or provide revenue-generating opportunities.
These acquisitions are part of Aditxt's broader strategy to expand its portfolio, enhance its technological capabilities, and drive long-term value creation. Updates on these initiatives will be provided as discussions progress.
Current Focus Areas (Subsidiaries)
Via Pearsanta™, advancing early cancer detection through precision diagnostics — with plans to develop adductomics-based screening to advance towards pre-cancer detection.
Visit PearsantaAdivue
Through Adivue™, advancing innovative solutions for neurodegenerative and neuroinflammatory conditions.
Planned Expansion Areas (Proposed Acquisitions)
Through Evofem™, addressing critical unmet needs in reproductive and sexual health.
Visit Evofem